S. Çomaklı Et Al. , "Quinacrine, a PLA2 inhibitor, alleviates LPS-induced acute kidney injury in rats: Involvement of TLR4/NF-κB/TNF α-mediated signaling," INTERNATIONAL IMMUNOPHARMACOLOGY , vol.126, 2024
Çomaklı, S. Et Al. 2024. Quinacrine, a PLA2 inhibitor, alleviates LPS-induced acute kidney injury in rats: Involvement of TLR4/NF-κB/TNF α-mediated signaling. INTERNATIONAL IMMUNOPHARMACOLOGY , vol.126 .
Çomaklı, S., Küçükler, S., Değirmençay, Ş., Bolat, İ., & Özdemir, S., (2024). Quinacrine, a PLA2 inhibitor, alleviates LPS-induced acute kidney injury in rats: Involvement of TLR4/NF-κB/TNF α-mediated signaling. INTERNATIONAL IMMUNOPHARMACOLOGY , vol.126.
Çomaklı, Selim Et Al. "Quinacrine, a PLA2 inhibitor, alleviates LPS-induced acute kidney injury in rats: Involvement of TLR4/NF-κB/TNF α-mediated signaling," INTERNATIONAL IMMUNOPHARMACOLOGY , vol.126, 2024
Çomaklı, Selim Et Al. "Quinacrine, a PLA2 inhibitor, alleviates LPS-induced acute kidney injury in rats: Involvement of TLR4/NF-κB/TNF α-mediated signaling." INTERNATIONAL IMMUNOPHARMACOLOGY , vol.126, 2024
Çomaklı, S. Et Al. (2024) . "Quinacrine, a PLA2 inhibitor, alleviates LPS-induced acute kidney injury in rats: Involvement of TLR4/NF-κB/TNF α-mediated signaling." INTERNATIONAL IMMUNOPHARMACOLOGY , vol.126.
@article{article, author={Selim ÇOMAKLI Et Al. }, title={Quinacrine, a PLA2 inhibitor, alleviates LPS-induced acute kidney injury in rats: Involvement of TLR4/NF-κB/TNF α-mediated signaling}, journal={INTERNATIONAL IMMUNOPHARMACOLOGY}, year=2024}